» ±¾Ìû¸½¼þ×ÊÔ´Áбí

• »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
  ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æȨÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
• ¸½¼þ 1 : Antibody_Engineering_Protocols_MMB51(1995).pdf
2014-08-26 11:29:28, 26.82 M
• ¸½¼þ 2 : Antibody_Engineering_volume2(2010).pdf
2014-08-26 11:29:56, 9.64 M
• ¸½¼þ 3 : Antibody_Engineering(2004).pdf
2014-08-26 11:30:09, 5.79 M
• ¸½¼þ 4 : Antibody_Engineering(2010).pdf
2014-08-26 11:30:48, 10.47 M
• ¸½¼þ 5 : Antibody_Expression_and_Production(2011).pdf
2014-08-26 11:31:07, 7.65 M
• ¸½¼þ 6 : Antibody_Methods_and_Protocols(2012).pdf
2014-08-26 11:31:24, 5.36 M
• ¸½¼þ 7 : Antibody_Phage_Display_2nd(2009).pdf
2014-08-26 11:31:33, 2.91 M
• ¸½¼þ 8 : Antibody_Phage_Display(2002).pdf
2014-08-26 11:31:47, 4.63 M
• ¸½¼þ 9 : Antibody-Drug_Conjugates_and_Immunotoxins(2013).pdf
2014-08-26 11:32:10, 7.7 M
• ¸½¼þ 10 : Antibody-Drug_Conjugates_MMB1045(2013).pdf
2014-08-26 11:32:27, 5.98 M
• ¸½¼þ 11 : Anticarbohydrate_Antibodies(2012).pdf
2014-08-26 11:33:05, 9.89 M
• ¸½¼þ 12 : Antigen_Processing_MMB960(2013).pdf
2014-08-26 11:33:30, 8.62 M
• ¸½¼þ 13 : Bispecific_Antibodies(2011).pdf
2014-08-26 11:33:58, 7.36 M
• ¸½¼þ 14 : Challenges_in_Infectious_Diseases(2013).pdf
2014-08-26 11:34:16, 4.6 M
• ¸½¼þ 15 : Current_Trends_in_Monoclonal_Antibody_Development_and_Manufacturing(2010).pdf
2014-08-26 11:34:38, 8.47 M
• ¸½¼þ 16 : Development_of_Antibody-Based_Therapeutics(2012).pdf
2014-08-26 11:35:03, 7.44 M
• ¸½¼þ 17 : Diagnostic_and_Therapeutic_Antibodies_MMM40(2000).pdf
2014-08-26 11:35:13, 3.13 M
• ¸½¼þ 18 : Drugs_for_HER-2-positive_Breast_Cancer(2011).pdf
2014-08-26 11:35:21, 1.42 M
• ¸½¼þ 19 : Glycosylation_Engineering_of_Biopharmaceuticals_MMB988(2013).pdf
2014-08-26 11:35:47, 10.07 M
• ¸½¼þ 20 : Human_Antibody_Therapeutics_for_Viral_Disease(2008).pdf
2014-08-26 11:35:58, 3.6 M
• ¸½¼þ 21 : Human_Monoclonal_Antibodies_MMB1060(2014).pdf
2014-08-26 11:36:12, 5.2 M
• ¸½¼þ 22 : Immuno_histochemistry=Basics_and_Methods(2010).pdf
2014-08-26 11:36:28, 3.72 M
• ¸½¼þ 23 : Immunochemical_Protocols_MMB295(2005).pdf
2014-08-26 11:36:38, 2.92 M
• ¸½¼þ 24 : Immunotherapy_of_Cancer_MMB651(2011).pdf
2014-08-26 11:36:53, 5.58 M
• ¸½¼þ 25 : Molecular_and_Cellular_Mechanisms_of_Antibody_Activity(2013).pdf
2014-08-26 11:37:13, 7.1 M
• ¸½¼þ 26 : Monoclonal_Antibodies_MMB378(2007).pdf
2014-08-26 11:37:28, 5.03 M
• ¸½¼þ 27 : Monoclonal_Antibodies_MMB1131(2014).pdf
2014-08-26 11:38:01, 11.46 M
• ¸½¼þ 28 : Monoclonal_Antibody_Protocols(1995).pdf
2014-08-26 11:38:56, 15.44 M
• ¸½¼þ 29 : Naturally_Occurring_Antibodies_(NAbs)(2012).pdf
2014-08-26 11:39:09, 4.1 M
• ¸½¼þ 30 : New_Antibody_Microarray_Tube_for_Cellular_Localization_and_Signaling_Pathways(2009).pdf
2014-08-26 11:39:23, 4.61 M
• ¸½¼þ 31 : Recombinant_Antibodies_for_Cancer_Therapy_MMB207(2003).pdf
2014-08-26 11:39:35, 4.48 M
• ¸½¼þ 32 : Resistance_to_Immunotherapeutic_Antibodies_in_Cancer(2013).pdf
2014-08-26 11:39:47, 4.38 M
• ¸½¼þ 33 : Signal_Transduction_Immunohistochemistry_MMB717(2011).pdf
2014-08-26 11:40:15, 10.77 M
• ¸½¼þ 34 : Single_Domain_Antibodies_MMB911(2012).pdf
2014-08-26 11:40:49, 9.36 M
• ¸½¼þ 35 : The_Complement_System_MMB1100(2014).pdf
2014-08-26 11:41:15, 7.14 M
• ¸½¼þ 36 : Therapeutic_Antibodies_MMB525(2009).pdf
2014-08-26 11:41:41, 9.03 M
• ¸½¼þ 37 : Therapeutic_Antibodies(2008).pdf
2014-08-26 11:42:01, 6.95 M

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ÉúÎïÀàµç×ÓÊé	ÓлúºÏ³ÉºÍ¹¤ÒÕ	·ÂÖÆÒ©Ñз¢É걨	ÉúÎïÒ½Ò©ÎÄÏ×Êé
ҽҩͼÊé	Êé¼®¼°ºÃÌù	ÉúÃüÊé¼®	ÉúÎïÒ½Ò©²Ù×÷¹æ³Ì
ÑøÒ»Õ«	ÉúÎïÖÆÆ·	¿¹Ì幤³Ì	ÉúÎïҽѧ×ÊÁÏ
ÅÔÃÅ×óµÀ	¹Û-¾«-¼Ç	ÐÂÒ©Ñз¢	»º¿ØÊÍÖƼÁ¿ª·¢
»¯Ñ§Ñ§Ï°	ÎÒµÄÊÕ²Ø	ÐÂÒ©Ñз¢	ÊÕ²Ø
ÎÒÐÄÒÀ¾É	¿¹ÌåÀà	Ò©ÎïÑз¢	×ÊÔ´²¿

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶